本页面由Tiger Trade Technology Pte. Ltd.提供服务

Fennec Pharmaceuticals Inc.

12.78
+1.8416.82%
盘后12.40-0.3770-2.95%19:34 EDT
成交量:72.00万
成交额:893.76万
市值:4.44亿
市盈率:-46.19
高:13.25
开:12.16
低:11.61
收:10.94
52周最高:13.25
52周最低:5.65
股本:3,471.28万
流通股本:1,650.41万
量比:3.68
换手率:4.36%
股息:- -
股息率:- -
每股收益(TTM):-0.2767
每股收益(LYR):-0.3409
净资产收益率:-52.68%
总资产收益率:-5.91%
市净率:11.78
市盈率(LYR):-37.49

数据加载中...

2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/11

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/22

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/23

重要事件披露

Form 8-K - Current report
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/24

重要事件披露

Form 8-K - Current report
2026/03/16

重要事件披露

Form 8-K - Current report